Table of Contents
1 Table of Contents 2
1.1 List of Tables 7
1.2 List of Figures 9
2
Introduction 11
2.1 What Is This Report About? 11
3 Executive Summary
12
4 Definitions of Markets Covered in the Report 13
4.1 Diabetic Care
Devices 13
4.2 Glucose Monitoring Devices 13
4.2.1 Blood Glucose
Meters 13
4.2.2 Blood Glucose Strips 13
4.3 Insulin Delivery 13
4.3.1 Insulin Pens 13
4.3.2 Insulin Syringes 14
4.3.3 Insulin Pumps
14
4.3.4 Traditional Insulin Pump Accessories 14
5 Healthcare Sector
Review 15
5.1 Healthcare Sector Review 15
5.2 Healthcare Expenditure
15
5.3 Healthcare Infrastructure 17
5.3.1 Healthcare Personnel Data
18
5.3.2 Healthcare Facilities Data 19
5.4 Healthcare Policy 20
6
Regulation System 21
6.1 Medical Equipment Approval Process 21
6.1.1
Classification 22
6.1.2 Conformity Assessment Process 31
6.1.3
Registration Fee 34
6.1.4 Registration Period 34
6.2 Post Market
Surveillance (PMS) 35
7 Pricing and Reimbursement 36
7.1 Pricing and
Reimbursement Policies 36
8 Distribution Structure 37
8.1 France
Medical Equipment Distribution Structure 37
9 Diabetes Care Devices In
France 38
9.1 Diabetes Care Devices, France, Overall Revenue ($ m),
2000-2015 38
9.2 Diabetes Care Devices, France, Category Volume (Units),
2000-2015 42
9.3 Diabetes Care Devices, France, Cross-Category Analysis,
2000-2015 44
9.4 Diabetes Care Devices, France, Company Share (2007-2008)
45
10 Glucose Monitoring In France 47
10.1 Glucose Monitoring Overall
Revenue (2000-2015) 47
10.1.1 Blood Glucose Meters Overall Revenue
(2000-2015) 50
10.2 Glucose Monitoring Overall Volume (2000-2015) 52
10.2.1 Blood Glucose Meters Overall Volume (2000-2015) 54
10.3 Glucose
Monitoring, France, Cross-Segment Analysis, 2000-2015 56
10.4 Glucose
Monitoring Average Price (2000-2015) 57
10.5 Glucose Monitoring Market
Dynamics 58
10.5.1 Market Drivers 58
10.5.2 Market Restraints 58
10.6 Glucose Monitoring Distribution Share (2007-2008) 58
10.7 Glucose
Monitoring, France, Company Share (2007-2008) 59
11 Insulin Delivery In
France 61
11.1 Insulin Delivery Overall Revenue (2000-2015) 61
11.1.1
Insulin Pens Overall Revenue (2000-2015) 65
11.2 Insulin Delivery Overall
Volume (2000-2015) 67
11.2.1 Insulin Pens Overall Volume (2000-2015)
68
11.3 Insulin Delivery, France, Cross-Segment Analysis, 2000-2015 70
11.4 Insulin Delivery Average Price (2000-2015) 71
11.5 Insulin Delivery
Market Dynamics 72
11.6 Insulin Delivery Distribution Share (2007-2008)
72
11.7 Insulin Delivery, France, Company Share (2007-2008) 73
12
Overview of Key Companies in France Diabetes Care Devices Market 75
12.1
F. Hoffmann-La Roche Ltd. 75
12.1.1 Company Overview 75
12.1.2 Value
Chain Analysis 76
12.1.3 F. Hoffmann-La Roche Ltd Pipeline Products 78
12.2 LifeScan, Inc. 78
12.2.1 Company Overview 78
12.2.2 LifeScan,
Inc. Pipeline Products 79
12.3 Abbott Laboratories 81
12.3.1 Company
Overview 81
12.3.2 Value Chain Analysis 81
12.3.3 Abbott Laboratories
Pipeline Products 83
12.4 Bayer HealthCare AG 86
12.4.1 Company
Overview 86
12.4.2 Value Chain Analysis 86
12.4.3 Bayer HealthCare AG
Pipeline Products 88
12.5 Novo Nordisk A/S 90
12.5.1 Company Overview
90
12.5.2 Novo Nordisk A/S Pipeline Products 90
12.6 Medtronic, Inc.
91
12.6.1 Company Overview 91
12.6.2 Value Chain Analysis 92
12.6.3 Medtronic, Inc. Pipeline Products 93
12.7 Becton, Dickinson and
Company 101
12.7.1 Company Overview 101
12.7.2 Value Chain Analysis
101
12.8 Eli Lilly and Company 103
12.8.1 Company Overview 103
12.8.2 Value Chain Analysis 103
12.8.3 Eli Lilly and Company Pipeline
Products 106
12.9 ARKRAY, Inc. 107
12.9.1 Company Overview 107
12.9.2 ARKRAY, Inc. Pipeline Products 107
12.10 Terumo Corporation 108
12.10.1 Company Overview 108
12.10.2 Value Chain Analysis 108
12.11
Animas Corporation 110
12.11.1 Company Overview 110
12.12
Sanofi-Aventis 111
12.12.1 Company Overview 111
12.13 Smiths Medical
111
12.13.1 Company Overview 111
12.13.2 Value Chain Analysis 112
13 Recent Developments 114
13.1 Strategy and Business Planning 114
13.1.1 May 18, 2009: Sanofi-aventis, DND Collaborate for Sleeping Sickness
Drug 114
14 Appendix 115
14.1 GlobalData Research Methodology 115
14.2 Coverage 116
14.3 Secondary Research 117
14.4 Primary Research
117
14.5 Models 118
14.6 Forecasts 118
14.7 Expert Panel
Validation 119
14.8 Currency Conversion 120
14.9 Contact Us 121
14.10 Disclaimer 121
1.1 List of Tables
Table 1: Number of
Doctors by Specialty in France, 2003-2007 18
Table 2: Number of Hospital
Wards by Specialty in France, 2003-2007 19
Table 3: Diabetes Care
Devices, France, Overall Revenue ($ m), Historic, 2000-2008 38
Table 4:
Diabetes Care Devices, France, Overall Revenue ($m), Forecast, 2008-2015
40
Table 5: Diabetes Care Devices, France, Category Volume (Units),
Historic, 2000-2008 42
Table 6: Diabetes Care Devices, France,
Category Volume (Units), Forecast, 2008-2015 43
Table 7: Diabetes Care
Devices, France, Cross-Category Analysis, 2000-2015 44
Table 8:
Diabetes Care Devices, France, Company Share by Revenue ($m), 2007-2008 45
Table 9: Glucose Monitoring, France, Revenue ($ m) by Segment, Historic,
2000-2008 47
Table 10: Glucose Monitoring, France, Revenue ($ m) by
Segment, Forecast, 2008-2015 49
Table 11: Blood Glucose Meters,
France, Revenue ($m) by Sub-Segment, Historic, 2000-2008 50
Table 12:
Blood Glucose Meters, France, Revenue ($m) by Sub-Segment, Forecast, 2008-2015
51
Table 13: Glucose Monitoring, France, Volume (Units) by Segment,
Historic, 2000-2008 52
Table 14: Glucose Monitoring, France, Volume
(Units) by Segment, Forecast, 2008-2015 53
Table 15: Blood Glucose
Meters, France, Volume (Units) by Sub-Segment, Historic, 2000-2008 54
Table 16: Blood Glucose Meters, France, Volume (Units) by Sub-Segment,
Forecast, 2008-2015 55
Table 17: Glucose Monitoring, France,
Cross-Segment Analysis, 2000-2015 56
Table 18: Glucose Monitoring,
France, Average Price ($), Historic, 2000-2008 57
Table 19: Glucose
Monitoring, France, Average Price ($), Forecast, 2008-2015 57
Table 20:
Glucose Monitoring, France, Distribution Share by Revenue ($m), 2007-2008
58
Table 21: Glucose Monitoring, France, Company Share by Revenue
($m), 2007-2008 59
Table 22: Insulin Delivery, France, Revenue ($ m)
by Segment, Historic, 2000-2008 61
Table 23: Insulin Delivery,
France, Revenue ($ m) by Segment, Forecast, 2008-2015 63
Table 24:
Insulin Pens, France, Revenue ($ m) by Sub-Segment, Historic, 2000-2008 65
Table 25: Insulin Pens, France, Revenue ($ m) by Sub-Segment, Forecast,
2008-2015 66
Table 26: Insulin Delivery, France, Volume (Units) by
Segment, Historic, 2000-2008 67
Table 27: Insulin Delivery, France,
Volume (Units) by Segment, Forecast, 2008-2015 67
Table 28: Insulin
Pens, France, Volume (Units) by Sub-Segment, Historic, 2000-2008 68
Table
29: Insulin Pens, France, Volume (Units) by Sub-Segment, Forecast,
2008-2015 69
Table 30: Insulin Delivery, France, Cross-Segment
Analysis, 2000-2015 70
Table 31: Insulin Delivery, France, Average
Price ($), Historic, 2000-2008 71
Table 32: Insulin Delivery, France,
Average Price ($), Forecast, 2008-2015 71
Table 33: Insulin Delivery,
France, Distribution Share by Revenue ($ m), 2007-2008 72
Table 34:
Insulin Delivery, France, Company Share by Revenue ($m), 2007-2008 73
Table 35: F. Hoffmann-La Roche Ltd Pipeline Products by Equipment Type
78
Table 36: F. Hoffmann-La Roche Ltd Pipeline Products by
Development Stage 78
Table 37: F. Hoffmann-La Roche Ltd Pipeline
Products by Therapy Area 78
Table 38: LifeScan, Inc. Pipeline
Products by Equipment Type 79
Table 39: LifeScan, Inc. Pipeline
Products by Development Stage 79
Table 40: LifeScan, Inc. Pipeline
Products by Therapy Area 79
Table 41: LifeScan, Inc. Pipeline
Products by Clinical Trials 80
Table 42: LifeScan, Inc. Pipeline
Products by News Summary 80
Table 43: Abbott Laboratories Pipeline
Products by Equipment Type 83
Table 44: Abbott Laboratories Pipeline
Products by Development Stage 84
Table 45: Abbott Laboratories
Pipeline Products by Therapy Area 84
Table 46: Abbott Laboratories
Pipeline Products by Clinical Trials 85
Table 47: Abbott
Laboratories Pipeline Products by News Summary 85
Table 48: Bayer
HealthCare AG Pipeline Products by Equipment Type 88
Table 49: Bayer
HealthCare AG Pipeline Products by Development Stage 88
Table 50:
Bayer HealthCare AG Pipeline Products by Therapy Area 89
Table 51:
Bayer HealthCare AG Pipeline Products by News Summary 89
Table 52:
Novo Nordisk A/S Pipeline Products by Equipment Type 90
Table 53:
Novo Nordisk A/S Pipeline Products By Development Stage 90
Table 54:
Novo Nordisk A/S Pipeline Products By Therapy Area 91
Table 55: Novo
Nordisk A/S Pipeline Products By Clinical Trials 91
Table 56:
Medtronic, Inc. Pipeline Products by Equipment Type 93
Table 57:
Medtronic, Inc. Pipeline Products By Development Stage 95
Table 58:
Medtronic, Inc. Pipeline Products By Therapy Area 97
Table 59:
Medtronic, Inc. Pipeline Products By Clinical Trials 99
Table 60:
Medtronic, Inc. Pipeline Products By News Summary 100
Table 61: Eli
Lilly and Company Pipeline Products by Equipment Type 106
Table 62:
Eli Lilly and Company Pipeline Products by Development Stage 106
Table 63:
Eli Lilly and Company Pipeline Products by Therapy Area 106
Table 64:
Eli Lilly and Company Pipeline Products by Clinical Trials 106
Table
65: Eli Lilly and Company Pipeline Products by News Summary 106
Table
66: ARKRAY, Inc. Pipeline Products by Equipment Type 107
Table 67:
ARKRAY, Inc. Pipeline Products by Development Stage 107
Table 68:
ARKRAY, Inc. Pipeline Products by Clinical Trials 107
Table 69:
ARKRAY, Inc. Pipeline Products by News Summary 108
Table 70: USD to
Local Currency, Average Exchange Rate 2008 120
1.2 List of
Figures
Figure 1: Total Healthcare Expenditure in France, 2000 –
2006 16
Figure 2: Flowchart for Classification of Non-invasive Devices in
France, 2007 23
Figure 3: Flowchart for Classification of Invasive Devices
in France, 2007 24
Figure 4: Flowchart for Classification of Invasive
Devices in France, 2007 25
Figure 5: Flowchart for Classification of
Invasive Devices in France, 2007 26
Figure 6: Flowchart for Classification
of Invasive Devices in France, 2007 27
Figure 7: Flowchart for
Classification of Active Devices in France, 2007 28
Figure 8: Flowchart
for Classification of Active Devices in France, 2007 29
Figure 9:
Flowchart for Classification of Devices except Non-invasive, Invasive and
Active Devices in France, 2007 30
Figure 10: Conformity Assessment of
Class-I Medical Devices in France, 2007 31
Figure 11: Conformity
Assessment of Class-IIa Medical Devices in France, 2007 32
Figure 12:
Conformity Assessment of Class-IIb Medical Devices in France, 2007 33
Figure 13: Conformity Assessment of Class-III Medical Devices in France, 2007
34
Figure 14: Medical Equipment Distribution Structure in France, 2007
37
Figure 15: Diabetes Care Devices, France, Overall Revenue ($ m),
Historic, 2000-2008 38
Figure 16: Diabetes Care Devices, France,
Overall Revenue ($ m), Forecast, 2008-2015 40
Figure 17: Diabetes
Care Devices, France, Category Volume (Units), Historic, 2000-2008 42
Figure 18: Diabetes Care Devices, France, Category Volume (Units),
Forecast, 2008-2015 43
Figure 19: Diabetes Care Devices, France,
Cross-Category Analysis, 2000-2015 44
Figure 20: Diabetes Care
Devices, France, Company Share (%), 2008 45
Figure 21: Glucose
Monitoring, France, Revenue ($ m) by Segment, Historic, 2000-2008 47
Figure 22: Glucose Monitoring, France, Revenue ($ m) by Segment,
Forecast, 2008-2015 49
Figure 23: Blood Glucose Meters, France,
Revenue ($ m) by Sub-Segment, Historic, 2000-2008 50
Figure 24: Blood
Glucose Meters, France, Revenue ($ m) by Sub-Segment, Forecast, 2008-2015
51
Figure 25: Glucose Monitoring, France, Volume (Units) by Segment,
Historic, 2000-2008 52
Figure 26: Glucose Monitoring, France, Volume
(Units) by Segment, Forecast, 2008-2015 53
Figure 27: Blood Glucose
Meters, France, Volume (Units) by Sub-Segment, Historic, 2000-2008 54
Figure 28: Blood Glucose Meters, France, Volume (Units) by Sub-Segment,
Forecast, 2008-2015 55
Figure 29: Glucose Monitoring, France,
Cross-Segment Analysis, 2000-2015 56
Figure 30: Glucose Monitoring,
France, Company Share (%), 2008 59
Figure 31: Insulin Delivery,
France, Revenue ($ m) by Segment, Historic, 2000-2008 61
Figure 32:
Insulin Delivery, France, Revenue ($ m) by Segment, Forecast, 2008-2015 63
Figure 33: Insulin Pens, France, Revenue ($ m) by Sub-Segment, Historic,
2000-2008 65
Figure 34: Insulin Pens, France, Revenue ($ m) by
Sub-Segment, Forecast, 2008-2015 66
Figure 35: Insulin Pens, France,
Volume (Units) by Sub-Segment, Historic, 2000-2008 68
Figure 36:
Insulin Pens, France, Volume (Units) by Sub-Segment, Forecast, 2008-2015
69
Figure 37: Insulin Delivery, France, Cross-Segment Analysis,
2000-2015 70
Figure 38: Insulin Delivery, France, Company Share (%),
2008 73
Figure 39: GlobalData Methodology 116
|
Related Report
|
View Cart
